News
FDA accepts NDA submission for Anaphylm; PDUFA date set for January 31, 2026Planning continues for a Q1 2026 U.S. launch of Anaphylm, if approved by the FDACompany accelerates Anaphylm global expansio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback